The Label · The Season, Not the Day
This name holds its distribution label.
Jin Medical International Ltd holds its Distribution at $1.90. Consolidating, no directional conviction, held for 2 days.
As held on the ledger · 2025-09-30
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 2 days |
| Price at the screen | $1.90 |
| Valuation | 9.50 trailing · N/A forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 7.34 |
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|
| Business activity |
Permissible |
Core business clean |
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. |
Pass |
| Debt load |
35.43% |
Below 33% |
Interest-bearing debt is 35.4% of its assets, above the one-third ceiling the screen allows. |
Fail |
| Interest-bearing cash |
41.54% |
Below 33% |
Interest-bearing cash and securities are 41.5% of assets, above the one-third limit. |
Fail |
| Receivables |
25.06% |
Below 49% |
Money owed to the company is 25.1% of assets, under the 49% limit. |
Pass |
| Revenue purity |
3.81% |
Below 5% |
Only 3.8% of revenue comes from non-compliant sources, under the 5% line. |
Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Business, in Plain Words
The fundamentals · plain-English read
| Trailing P/E | 9.5xvery cheap relative to earnings |
| EPS, trailing | 0.20 |
| Revenue growth | -16.5%revenue is shrinking |
| Profit margin | 5.8%thin but positive margins |
| Return on equity | 4.8%a modest return on shareholder capital |
| FCF yield | -34.37% |
| Debt to equity | 0.64moderate, manageable leverage |
| Current ratio | 1.86healthy short-term liquidity |
| Beta | 7.34much more volatile than the market |
| Short interest, float | 0.01% |
| 52-week range | 1.64 - 17.18 |
| Moat | NONE |
| Market cap | $15M |
| Employees | 273 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ZJYL trades on NASDAQ (the company is based in China). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.